格隆汇5月11日丨晶泰控股-P(02228.HK)公告,于2025年5月10日,买方深圳晶泰科技有限公司(公司全资附属公司)、卖方(宁波梅山保税港区弘睦维投资管理合伙企业、宁波梅山保税港区弘睦和投资管理合伙企业、上海弘和维医学科技)、担保人及目标公司订立协议,根据该协议,买方已有条件同意购买,而卖方已有条件同意出售目标公司上海四维医学科技有限公司90%的股权,对价为人民币2.5亿元,待以现金方式...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.